Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 7;68:1605526. doi: 10.3389/ijph.2023.1605526

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Jiesisibieke, Liu, Yang, Chien and Tung.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Forest plots of COVID-19 vaccination safety (Global, 2021). (A) The pooled risk ratio of local adverse events associated with messenger Ribonucleic acid vaccination. (B) The pooled risk ratio of systemic adverse events associated with messenger Ribonucleic acid vaccination. (C) The pooled risk ratio of any adverse events associated with messenger Ribonucleic acid vaccination. (D) The pooled risk ratio of local adverse events associated with adenovirus vector vaccination. (E) The pooled risk ratio of any adverse events associated with adenovirus vector vaccination. (F) The pooled odds ratio of systemic adverse events associated with messenger Ribonucleic acid vaccination. (G) The pooled odds ratio of systemic adverse events associated with messenger Ribonucleic acid vaccination. (H) The pooled odds ratio of local adverse events associated with adenovirus vector vaccination. (I) The pooled odds ratio of systemic adverse events associated with adenovirus vector vaccination. (J) The pooled odds ratio of local adverse events associated with subunit vaccination. (K) The pooled odds ratio of systemic adverse events associated with subunit vaccination. (L) The pooled risk ratio of other adverse events associated with overall COVID-19 vaccination. (M) The pooled odds ratio of local adverse events associated with inactivated vaccination. (N) The pooled odds ratio of systemic adverse events associated with inactivated vaccination. (O) The pooled prevalence of ant adverse events associated with overall COVID-19 vaccination.